Title: LegoChem
announces patent for a manufacturing method of methane…
Publication: Disclosed
on Kosdaq
Date: 14 July 2014
URL: link to website (contents
in Korean)
Summary
LegoChem Biosciences received a
patent on July 14, for a manufacturing method of methane for PAR-2 inhibitor. (Patent
number of 10-2012-0155892)
About LegoChem Biosciences
LegoChem Biosciences, Inc. (LCB) is a
research-based biotechnology company dedicated to discovering, developing, and
commercializing innovative medicines by leveraging our chemistry expertise to
make conventional biologics targeted and more potent for the benefit of
patients with diseases of high unmet medical needs. We are advancing
sustainable pipelines in therapeutic areas in antibiotics, anti-coagulants,
oncology, antibody-drug conjugate (ADC), and protein-drug conjugate (PDC).
|
|
IP : 106.243.208.*** 
|
